All countries
Fuel cell market projected to soar to $37.22b by 2034 on 14.8% CAGR
Fuel cell market projected to soar to $37.22b by 2034 on 14.8% CAGR
PEM fuel cells account for over 59% share.
Automation push to fuel 8.5% CAGR in pharma robot market through 2034
The market is estimated to ve valued at $226.24m in 2025.
Agentic AI cuts drug development timelines: report
Healthcare GenAI market seen growing to $22b by 2027.
Biopharma firms face $275b patent cliff as returns stall
BCG says pricing pressure, tariffs, and MFN policies are reshaping business models.
Personalised medicine to drive 17% CAGR in healthcare 3D printing, $14.6b by 2033
Patient-specific devices and orthopaedics drive market growth.
Medical fibre optics to hit $1.5b by 2030 as minimally invasive surgery surges
The 6.2% CAGR reflects global growth in high-resolution diagnostic fibres and biomedical sensing.
Medical simulation market set to reach $7.23b by 2030
Forecast implies 15.6% annual growth.
AI patient engagement market hits $33.68b by 2032
The report projects 20.9% annual growth as cloud deployments dominate due to lower costs.
Healthcare asset tracking to hit $22.4b as hospitals go digital
Market to adopt AI, 5G, and blockchain for healthcare efficiency.
VPD outbreak risks loom as coverage falls below 85%: report
A vaccine-preventable disease outbreak may be caused by routine immunisation gaps, donor fatigue, and complex programmes.
Digital pathology market to hit $3.2b in 2031 as AI overhauls oncology diagnostics
North America, Europe, Pacific Asia regions drive the market growth.
$3b mechanical surge replaces traditional nursing care
Hospitals force robotic growth to end labor crisis.
Global healthcare PE hits $191b in 2025, report says
Europe, North America and Asia-Pacific led the healthcare PE surge.
Agentic AI to unlock $120m in healthcare system savings
The tool encompasses patient interactions and end-to-end administrative processes.
AI forces 70% cut in hospital processing time
Midcycle automation killed paperwork.
CNS drug market to hit $235.9b by 2033 as neurological diseases surge
Mergers and licensing deals are accelerating as the global market valuation nears quarter-trillion mark.
6MM macrophage activation syndrome market eyes 24.7% CAGR growth until 2034
The market was valued at $110m in 2024.
Most Read
1. Sunway Healthcare targets $4.34b market cap with Malaysia IPO 2. 2026 biotech playbook: Hong Kong at the centre of China’s globalisation 3. iX Biopharma secures $52.8m US contract for pain reliever trials 4. Aging population drives demand for durable medical equipment market 5. Hong Kong outlines ‘One plus Three’ model for life and health tech R&DResource Center
Read Here
Advertise
Sign Up
Events
Event News
He discusses how healthcare systems in Asia Pacific need to evolve beyond simply expanding coverage and towards delivering equitable, sustainable, and high-impact care.
Commentary
2026 biotech playbook: Hong Kong at the centre of China’s globalisation